Fatemeh Esna-Ashari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fatemeh Esna-Ashari has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
A Foroughi
Human Viral Vaccines Department, Razi Vaccine and Serum Research Institute, karaj, Iran
1 shared publicationA Mohammadi
Human Viral Vaccines Department, Razi Vaccine and Serum Research Institute, karaj, Iran
1 shared publication- Abbas Shafyi
Human Viral Vaccines Department, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran
1 shared publication - Amir Hamta
Pediatrics Clinical Research Development Center, Qom University of Medical Sciences, Qom, Iran
1 shared publication - Ashraf Mohammadi
Human Viral Vaccines Department, Razi Vaccine and Serum Research Institute (RVSRI), Hessark Karadj, Agricultural Research, Education and Extension Organization (AREEO), Karaj, IR Iran
1 shared publication - Ashraf Mohammadi
Department of Human Viral Vaccines, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization, Karaj, Iran
1 shared publication
Latest Publications
- Open Access
- 15 April 2019
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 17 (6) , 586-593
Induction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production
Preparation of the indigenous varicella zoster vaccine could significantly reduce the disease burden of varicella zoster virus especially in immunosuppressed children. To achieve this goal, the varicella zoster virus was isolated from an 8 years boy infected with chicken pox. The virus was cultivated in sensitive cell line and determined varicella zoster. The adaptation and attenuation of virus was carried out after several passages in MRC-5 cell culture, Primary Guinea pig embryo fibroblast cell culture and again switching in MRC-5 cell culture. The challenged of vaccine dose was found 3LogCCID50. Following two doses of immunization in guinea pigs via inoculated cell culture-fluid attenuated- local isolated VZV at zero and 14 day, the humoral immune response, varicella-zoster virus (VZV) IgG and IgM were determined using enzyme-linked Immunosorbent and seroneutralization assays at 7, 14, 21, 30, 60, 90.120 days after receiving of the first and second dose of vaccine. The results of immunization showed good 93% seroconversion in guinea pig which compared with vOKa vaccine was not significant (p<0.05). The prepared attenuate varicella zoster virus promising a candidate Virus for our future plan to vaccine production.
- 15 April 2019
- Published by Knowledge E DMCC in Iranian Journal of Allergy, Asthma and Immunology
- Vol. 17 (6) , 586-593
Open AccessInduction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production
Preparation of the indigenous varicella zoster vaccine could significantly reduce the disease burden of varicella zoster virus especially in immunosuppressed children. To achieve this goal, the varicella zoster virus was isolated from an 8 years boy infected with chicken pox. The virus was cultivated in sensitive cell line and determined varicella zoster. The adaptation and attenuation of virus was carried out after several passages in MRC-5 cell culture, Primary Guinea pig embryo fibroblast cell culture and again switching in MRC-5 cell culture. The challenged of vaccine dose was found 3LogCCID50. Following two doses of immunization in guinea pigs via inoculated cell culture-fluid attenuated- local isolated VZV at zero and 14 day, the humoral immune response, varicella-zoster virus (VZV) IgG and IgM were determined using enzyme-linked Immunosorbent and seroneutralization assays at 7, 14, 21, 30, 60, 90.120 days after receiving of the first and second dose of vaccine. The results of immunization showed good 93% seroconversion in guinea pig which compared with vOKa vaccine was not significant (p<0.05). The prepared attenuate varicella zoster virus promising a candidate Virus for our future plan to vaccine production.
- 1 February 2019
- Published by Elsevier in Journal of Virological Methods
- Vol. 264, 18-22
Evaluation of the thermal stability of live-attenuated Rubella vaccine (Takahashi strain) formulated and lyophilized in different stabilizers
- 1 February 2019
- Published by Elsevier in Journal of Virological Methods
- Vol. 264, 18-22
Evaluation of the thermal stability of live-attenuated Rubella vaccine (Takahashi strain) formulated and lyophilized in different stabilizers
- Open Access
- 1 November 2012
- Published by Definitive International Institute of Life Science (DIILI Publication) in Iranian Journal of Virology
- Vol. 6 (4) , 20-26
Evaluation of Cell Mediated Immunity following Rubella Vaccination Using Lymphocyte Proliferation
Iranian Journal of Virology مجله ویروس شناسی ایران
- 1 November 2012
- Published by Definitive International Institute of Life Science (DIILI Publication) in Iranian Journal of Virology
- Vol. 6 (4) , 20-26
Open AccessEvaluation of Cell Mediated Immunity following Rubella Vaccination Using Lymphocyte Proliferation
Iranian Journal of Virology مجله ویروس شناسی ایران